John Brooks Averette, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 |
Ashley Long, FNP Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 |
Samuel C Pace, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 |
Patrick Stephen Harris, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 589 Garfield St Ste 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-280-5654 |
Roger L Huey, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 |
Barney Guyton, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 |
Albert F Chiemprabha, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1815 Mission 66, Vicksburg, MS 39180 Phone: 601-355-1234 Fax: 601-326-3559 |
Yoshinobu Namihira, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3000 Halls Ferry Rd, Vicksburg, MS 39180 Phone: 601-638-9800 Fax: 601-638-9808 |
News Archive
Just like our senses of hearing and vision, our sense of touch plays an important role in how we perceive and interact with the world around us.
Researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research, have discovered that the number of myeloid-derived suppressor cells (MDSC) is increased in the blood of patients with idiopathic pulmonary fibrosis (IPF).
The UC Davis Clinical Translational Science Center (CTSC) received notice of its third National Institutes of Health (NIH) award renewal, a vote of confidence in the center's ability to advance outstanding research in human health.
Today Biogen Idec announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (RMS).
› Verified 7 days ago